Back to Search
Start Over
Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil.
- Source :
-
International journal of pharmaceutics [Int J Pharm] 2006 Jul 24; Vol. 317 (2), pp. 155-60. Date of Electronic Publication: 2006 Mar 12. - Publication Year :
- 2006
-
Abstract
- Learning about the behavior of a drug in biological environment enables application of better formulation strategies to improve bioavailability of the same. Cefpodoxime proxetil (CP) is a prodrug, which is orally administered cephalosporin with only 50% absolute bioavailability. Despite previous studies, reasons responsible for low bioavailability of CP remain poorly understood. The present study tries to ascertain reasons for the low oral bioavailability of CP. The in vitro, in situ and ex vivo studies showed interesting results, where metabolism of CP into cefpodoxime acid (CA) inside the intestinal epithelial cell and preferential efflux of CA into lumen was identified as primary reason for low oral bioavailability of CP. Presence of specific carriers or transportation mechanism on the apical side membrane of enterocyte, than basal side of the same was observed.
- Subjects :
- Administration, Oral
Animals
Biological Availability
Ceftizoxime pharmacokinetics
Enterocytes metabolism
Gastric Mucosa metabolism
Hydrogen-Ion Concentration
In Vitro Techniques
Jejunum enzymology
Jejunum metabolism
Male
Rats
Rats, Sprague-Dawley
Cefpodoxime Proxetil
Anti-Bacterial Agents pharmacokinetics
Ceftizoxime analogs & derivatives
Prodrugs pharmacokinetics
Subjects
Details
- Language :
- English
- ISSN :
- 0378-5173
- Volume :
- 317
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- International journal of pharmaceutics
- Publication Type :
- Academic Journal
- Accession number :
- 16621365
- Full Text :
- https://doi.org/10.1016/j.ijpharm.2006.03.004